MA34227B1 - Procédé de préparation de compositions pharmaceutiques destinées à une administration orale, comprenant un ou plusieurs principes actifs, et compositions les comprenant - Google Patents
Procédé de préparation de compositions pharmaceutiques destinées à une administration orale, comprenant un ou plusieurs principes actifs, et compositions les comprenantInfo
- Publication number
- MA34227B1 MA34227B1 MA35363A MA35363A MA34227B1 MA 34227 B1 MA34227 B1 MA 34227B1 MA 35363 A MA35363 A MA 35363A MA 35363 A MA35363 A MA 35363A MA 34227 B1 MA34227 B1 MA 34227B1
- Authority
- MA
- Morocco
- Prior art keywords
- compositions
- same
- active ingredients
- oral administration
- preparing pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/005—Coating of tablets or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Paints Or Removers (AREA)
Abstract
La présente invention porte sur un procédé d'« enrobage par fusion » de principes actifs pharmaceutiques, caractérisé par des propriétés organoleptiques ou physicochimiques qu'il est souhaitable de masquer. L'invention porte aussi sur les principes actifs médicaux obtenus, dont les propriétés organoleptiques ou physicochimiques ont été masquées, et sur les compositions qui les contiennent.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1053034A FR2959130A1 (fr) | 2010-04-21 | 2010-04-21 | Procede de preparation de compositions pharmaceutiques destinees a l'administration par voie orale comprenant un ou plusieurs principes actifs et les compositions les comprenant. |
PCT/IB2011/051736 WO2011132167A1 (fr) | 2010-04-21 | 2011-04-20 | Procédé de préparation de compositions pharmaceutiques destinées à une administration orale, comprenant un ou plusieurs principes actifs, et compositions les comprenant |
Publications (1)
Publication Number | Publication Date |
---|---|
MA34227B1 true MA34227B1 (fr) | 2013-05-02 |
Family
ID=42797556
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA35362A MA34226B1 (fr) | 2010-04-21 | 2011-04-20 | Composition à base de fexofènadine et procede de préparation pour celle-ci |
MA35363A MA34227B1 (fr) | 2010-04-21 | 2011-04-20 | Procédé de préparation de compositions pharmaceutiques destinées à une administration orale, comprenant un ou plusieurs principes actifs, et compositions les comprenant |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA35362A MA34226B1 (fr) | 2010-04-21 | 2011-04-20 | Composition à base de fexofènadine et procede de préparation pour celle-ci |
Country Status (22)
Country | Link |
---|---|
US (2) | US20130183382A1 (fr) |
EP (2) | EP2560612B1 (fr) |
JP (2) | JP2013525341A (fr) |
KR (2) | KR20130094716A (fr) |
CN (2) | CN103002874B (fr) |
AR (2) | AR081539A1 (fr) |
AU (2) | AU2011244020A1 (fr) |
BR (2) | BR112012026938A2 (fr) |
CA (2) | CA2796816A1 (fr) |
CL (2) | CL2012002898A1 (fr) |
CO (2) | CO6620042A2 (fr) |
EA (2) | EA201291089A1 (fr) |
ES (2) | ES2525163T3 (fr) |
FR (1) | FR2959130A1 (fr) |
IL (2) | IL222578A0 (fr) |
MA (2) | MA34226B1 (fr) |
MX (1) | MX2012012275A (fr) |
PL (2) | PL2560612T3 (fr) |
SG (3) | SG10201506708UA (fr) |
TW (2) | TW201204415A (fr) |
UY (2) | UY33350A (fr) |
WO (2) | WO2011132167A1 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102349889B (zh) * | 2011-11-01 | 2013-08-28 | 江苏先声药物研究有限公司 | 一种含有决奈达隆的组合物 |
JP5841433B2 (ja) * | 2012-01-11 | 2016-01-13 | 日東電工株式会社 | 口腔内フィルム状基剤及び製剤 |
JP6245677B2 (ja) * | 2012-01-20 | 2017-12-13 | ニプロ株式会社 | 口腔内崩壊錠 |
JP6255908B2 (ja) * | 2012-11-09 | 2018-01-10 | 大正製薬株式会社 | 固形製剤 |
FR2999937B1 (fr) * | 2012-12-21 | 2015-01-09 | Sanofi Sa | Unite solide a haute teneur en fexofenadine et son procede de preparation |
CN104274408A (zh) * | 2013-07-10 | 2015-01-14 | 北京科信必成医药科技发展有限公司 | 一种熔融包衣的速释药物微粒及其制备方法 |
CN103610645B (zh) * | 2013-11-25 | 2016-05-11 | 浙江万晟药业有限公司 | 一种非索非那定盐酸盐的药物组合物及制备方法 |
US9132096B1 (en) | 2014-09-12 | 2015-09-15 | Alkermes Pharma Ireland Limited | Abuse resistant pharmaceutical compositions |
WO2016120299A1 (fr) * | 2015-01-28 | 2016-08-04 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Formulations de dronédarone à délitement buccal |
WO2017093890A1 (fr) * | 2015-11-30 | 2017-06-08 | Piramal Enterprises Limited | Formulation de comprimé à base de clobazam et son procédé de préparation |
EP3363429A1 (fr) * | 2017-02-20 | 2018-08-22 | DSM IP Assets B.V. | Procédé pour la production de particules enrobées |
EP3670489A1 (fr) * | 2018-12-21 | 2020-06-24 | Dompé farmaceutici S.p.A. | Co-cristal de kétoprofène, compositions le comprenant, son procédé de production et ses utilisations |
JP2023549381A (ja) | 2020-11-18 | 2023-11-24 | バイオファーマ・シナジーズ,エス.エル. | 抗ヒスタミン活性化合物を含む口内分散性粉末組成物 |
WO2022175829A1 (fr) | 2021-02-17 | 2022-08-25 | Cellix Bio Private Limited | Formulations et compositions topiques |
AU2021480621A1 (en) * | 2021-12-29 | 2024-07-18 | Opella Healthcare Group Sas | Compositions containing fexofenadine |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL193682C (nl) * | 1987-05-14 | 2000-07-04 | Glaxo Group Ltd | Beklede cefuroximaxetilsamenstelling. |
JPH07100665B2 (ja) * | 1987-12-23 | 1995-11-01 | 信越化学工業株式会社 | 被覆薬剤の製造方法 |
US5296236A (en) * | 1988-09-16 | 1994-03-22 | Recordati S.A., Chemical And Pharmaceutical Company | Controlled release therapeutic system for a liquid pharmaceutical formulations |
US5578322A (en) * | 1990-11-30 | 1996-11-26 | Yamanouchi Pharmaceutical Co., Ltd. | Quick release coated preparation |
EP0559897B1 (fr) | 1990-11-30 | 1998-03-04 | Yamanouchi Pharmaceutical Co. Ltd. | Preparation enrobee a liberation rapide |
MX9306393A (es) * | 1992-10-16 | 1994-04-29 | Glaxo Group Ltd | Composiciones de ranitidina substancialmente libres de sabor amargo, proceso para su preparacion y composiciones farmaceuticas que las contienen. |
CN1090935C (zh) | 1995-02-28 | 2002-09-18 | 阿温蒂斯药物公司 | 哌啶子基烷醇化合物的药物组合物 |
US5846632A (en) * | 1995-06-29 | 1998-12-08 | Eastman Kodak Company | Transfer support and method for fusing a transferrable image to a digital disc |
IT1276160B1 (it) * | 1995-11-22 | 1997-10-27 | Recordati Chem Pharm | Composizioni farmaceutiche orali a pronto rilascio per sospensioni estemporanee |
FR2753904B1 (fr) * | 1996-10-01 | 1998-10-30 | Gattefosse Ets Sa | Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication |
US5891476A (en) * | 1997-12-22 | 1999-04-06 | Reo; Joe P. | Tastemasked pharmaceutical system |
US6274162B1 (en) * | 2000-01-14 | 2001-08-14 | Bpsi Holdings, Inc. | Elegant film coating system |
FR2811912B1 (fr) * | 2000-07-21 | 2003-02-07 | Gattefosse Ets Sa | Procede d'enrobage de particules solides par un agent thermofusible, et particules solides ainsi enrobees |
UA80393C2 (uk) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
US6723348B2 (en) * | 2001-11-16 | 2004-04-20 | Ethypharm | Orodispersible tablets containing fexofenadine |
FR2838647B1 (fr) * | 2002-04-23 | 2006-02-17 | Particules enrobees a liberation prolongee, leur procede de preparation et comprimes les contenant | |
WO2004016247A1 (fr) * | 2002-08-14 | 2004-02-26 | E.I. Du Pont De Nemours And Company | Procede d'enrobage d'une particule pharmaceutique |
FR2848855B1 (fr) | 2002-12-23 | 2005-02-11 | Aventis Pharma Sa | Compositions pour administration orale de principes actifs necessitant un masquage du gout |
ES2272914T3 (es) * | 2003-05-20 | 2007-05-01 | Ethypharm | Composicion farmaceutica oral de liberacion sostenida. |
FR2857263B1 (fr) * | 2003-07-09 | 2005-09-09 | Sanofi Synthelabo | Nouvelle composition pharmaceutique solide comprenant de l'amisulpride |
WO2005062722A2 (fr) * | 2003-11-21 | 2005-07-14 | Sun Pharmaceutical Industries Limited | Composition pharmaceutique orale |
WO2005065639A2 (fr) * | 2003-11-21 | 2005-07-21 | Torrent Pharmaceuticals Limited | Nouvelles compositions pharmaceutiques |
DE602004023764D1 (de) | 2004-03-19 | 2009-12-03 | Zentiva Kimyasal Ueruenler San | Herstellung von lipid-beschichtetem cefuroxime axetil |
US20070048373A1 (en) * | 2005-08-30 | 2007-03-01 | Cima Labs Inc. | Dried milled granulate and methods |
-
2010
- 2010-04-21 FR FR1053034A patent/FR2959130A1/fr not_active Withdrawn
-
2011
- 2011-04-20 AU AU2011244020A patent/AU2011244020A1/en not_active Abandoned
- 2011-04-20 EP EP11722553.2A patent/EP2560612B1/fr not_active Revoked
- 2011-04-20 SG SG10201506708UA patent/SG10201506708UA/en unknown
- 2011-04-20 WO PCT/IB2011/051736 patent/WO2011132167A1/fr active Application Filing
- 2011-04-20 PL PL11722553T patent/PL2560612T3/pl unknown
- 2011-04-20 MA MA35362A patent/MA34226B1/fr unknown
- 2011-04-20 ES ES11722553.2T patent/ES2525163T3/es active Active
- 2011-04-20 EA EA201291089A patent/EA201291089A1/ru unknown
- 2011-04-20 BR BR112012026938A patent/BR112012026938A2/pt not_active IP Right Cessation
- 2011-04-20 AR ARP110101365A patent/AR081539A1/es not_active Application Discontinuation
- 2011-04-20 SG SG2012077772A patent/SG184951A1/en unknown
- 2011-04-20 JP JP2013505595A patent/JP2013525341A/ja active Pending
- 2011-04-20 JP JP2013505569A patent/JP2013525340A/ja active Pending
- 2011-04-20 MA MA35363A patent/MA34227B1/fr unknown
- 2011-04-20 EA EA201291088A patent/EA201291088A1/ru unknown
- 2011-04-20 PL PL11764289T patent/PL2560613T3/pl unknown
- 2011-04-20 KR KR1020127030328A patent/KR20130094716A/ko not_active Application Discontinuation
- 2011-04-20 CA CA2796816A patent/CA2796816A1/fr not_active Abandoned
- 2011-04-20 AR ARP110101364A patent/AR080934A1/es not_active Application Discontinuation
- 2011-04-20 CN CN201180020130.6A patent/CN103002874B/zh not_active Expired - Fee Related
- 2011-04-20 WO PCT/IB2011/002000 patent/WO2011151733A2/fr active Application Filing
- 2011-04-20 BR BR112012026596A patent/BR112012026596A2/pt not_active IP Right Cessation
- 2011-04-20 CA CA2796821A patent/CA2796821A1/fr not_active Abandoned
- 2011-04-20 KR KR1020127027293A patent/KR20130080428A/ko not_active Application Discontinuation
- 2011-04-20 AU AU2011262319A patent/AU2011262319A1/en not_active Abandoned
- 2011-04-20 MX MX2012012275A patent/MX2012012275A/es not_active Application Discontinuation
- 2011-04-20 SG SG2012077764A patent/SG184950A1/en unknown
- 2011-04-20 EP EP11764289.2A patent/EP2560613B1/fr not_active Not-in-force
- 2011-04-20 CN CN2011800306473A patent/CN102946857A/zh active Pending
- 2011-04-20 ES ES11764289.2T patent/ES2527390T3/es active Active
- 2011-04-21 TW TW100113943A patent/TW201204415A/zh unknown
- 2011-04-21 TW TW100113944A patent/TWI478713B/zh not_active IP Right Cessation
- 2011-04-25 UY UY0001033350A patent/UY33350A/es not_active Application Discontinuation
- 2011-04-25 UY UY0001033351A patent/UY33351A/es not_active Application Discontinuation
-
2012
- 2012-10-17 CL CL2012002898A patent/CL2012002898A1/es unknown
- 2012-10-18 CL CL2012002909A patent/CL2012002909A1/es unknown
- 2012-10-18 CO CO12184708A patent/CO6620042A2/es not_active Application Discontinuation
- 2012-10-19 CO CO12185243A patent/CO6620043A2/es not_active Application Discontinuation
- 2012-10-21 IL IL222578A patent/IL222578A0/en unknown
- 2012-10-21 IL IL222576A patent/IL222576A0/en unknown
- 2012-10-22 US US13/657,396 patent/US20130183382A1/en not_active Abandoned
- 2012-10-22 US US13/657,404 patent/US20130251794A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA34227B1 (fr) | Procédé de préparation de compositions pharmaceutiques destinées à une administration orale, comprenant un ou plusieurs principes actifs, et compositions les comprenant | |
MX2016010213A (es) | Formulaciones farmaceuticas novedosas. | |
TN2012000074A1 (fr) | Derives de thieno [2, 3-b] pyridine servant d'inhibiteurs de replication virale | |
MX2012007410A (es) | Compuestos antivirales novedosos. | |
EA201100032A1 (ru) | Соединения пиридина | |
WO2017083304A8 (fr) | Compositions thérapeutiques pour le traitement du virus de l'immunodéficience humaine | |
MA34045B1 (fr) | Ligands sigma destinés à être utilisés pour la prévention et/ou le traitement de la douleur postopératoire | |
TNSN06439A1 (fr) | Derives de 2-carbamide -4-phenylthiazole, leur preparation et leur application en therapeutique | |
IN2014MN00139A (fr) | ||
EA202090573A1 (ru) | Составы нирапариба | |
WO2017128917A8 (fr) | Dérivés de cycles condensés de parazole et procédé de préparation de ces derniers, et application de ces derniers dans le traitement de cancers, d'inflammation et de maladies immunitaires | |
DE602008003404D1 (de) | 5,6,7,8-tetrahydropteridin-derivate als hsp90-hemmer | |
MX2021010046A (es) | Nueva composicion terapeutica que contiene ingrediente activo de apomorfinas. | |
EP4282414A3 (fr) | Formulations de comprimés à libération modifiée contenant des inhibiteurs de phosphodiestérase | |
MX2021009539A (es) | Derivado del profarmaco 6-oxo-1,6-dihidropiridazina, metodo de preparacion del mismo y aplicacion del mismo en medicina. | |
PH12021550878A1 (en) | Cyclodextrin-based formulation of a bcl-2 inhibitor | |
MX2019003470A (es) | Composicion farmaceutica y metodo para el tratamiento de la enfermedad del higado graso no alcoholico. | |
EP4335509A3 (fr) | Nouveaux inhibiteurs de glutaminyl cyclase et leur utilisation dans le traitement de diverses maladies | |
MX2019014321A (es) | Compuestos biciclicos 5,6-fusionados y composiciones para el tratamiento de enfermedades parasitarias. | |
MX2013002649A (es) | Agente terapeutico contra el dolor. | |
MA33979B1 (fr) | Piperazines en tant qu'agents antipaludiques | |
ZA202200331B (en) | Naltrexone formulation | |
MX2022015232A (es) | Composicion farmaceutica acuosa de levilimab y su uso. | |
DK2091520T3 (da) | Oral doseringsform omfattende trisubstituerede glycerol-forbindelser | |
MA30179B1 (fr) | Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique. |